Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case-control analysis

Ruth Topless1, Ralph Green2, Sarah L Morgan3

  • 1Department of Biochemistry, University of Otago, Dunedin, New Zealand.

BMJ Open
|August 24, 2022
PubMed

Insights

Folic acid supplementation was linked to a higher risk of COVID-19 diagnosis and death. Methotrexate prescription did not increase COVID-19 risk and may reduce associated mortality risks.

Area of Science:

  • Epidemiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Folic acid and methotrexate are commonly prescribed medications.
  • Their potential impact on COVID-19 risk and outcomes is not fully understood.

Purpose of the Study:

  • To investigate the association between folic acid or methotrexate prescription and the risk of COVID-19 diagnosis and mortality.

Main Methods:

  • A case-control study using UK Biobank data from over 380,000 participants.
  • Multivariable logistic regression analyzed COVID-19 diagnosis and mortality, adjusting for numerous covariates.

Main Results:

  • Folic acid supplementation was associated with increased COVID-19 diagnosis (OR 1.51) and COVID-19-related death (OR 2.64).
  • Methotrexate prescription, with or without folic acid, was not significantly associated with COVID-19 diagnosis or mortality.

Conclusions:

  • Folic acid supplementation is associated with higher risks of COVID-19 diagnosis and mortality.
  • Methotrexate may potentially mitigate these risks, warranting further investigation.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.6K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
243
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
432
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
556
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.2K